Department of Plant Pathology, North Dakota State University, Fargo 58105.
Plant Dis. 2018 Mar;102(3):656-665. doi: 10.1094/PDIS-06-17-0853-RE. Epub 2018 Jan 31.
Succinate dehydrogenase-inhibiting (SDHI) fungicides have been widely applied in commercial potato (Solanum tuberosum L.) fields for the control of early blight, caused by Alternaria solani Sorauer. Five-point mutations on three AsSdh genes in A. solani have been identified as conferring resistance to SDHI fungicides. Recent work in our laboratory determined that A. solani isolates possessing the D123E mutation, or the substitution of aspartic acid for glutamic acid at position 123 in the AsSdhD gene, were collected at successively higher frequencies throughout a 3-year survey. In total, 118 A. solani isolates previously characterized as possessing the D123E mutation were evaluated in vitro for boscalid and fluopyram sensitivity. Over 80% of A. solani isolates with the D123E mutation evaluated were determined to be highly resistant to boscalid in vitro. However, effective concentration at which the fungal growth is inhibited by 50% values of isolates with the D123E mutation to fluopyram, ranging from 0.2 to 3 µg/ml, were sensitive and only slightly higher than those of baseline isolates to fluopyram, which ranged from 0.1 to 0.6 µg/ml. Five A. solani isolates with the D123E mutation were further evaluated in vivo for percent disease control obtained from boscalid and fluopyram compared with two wild-type isolates, three isolates possessing the F129L mutation, two isolates possessing the H134R mutation, two isolates possessing the H133R mutation, and one isolate with the H278R mutation. Relative area under the dose response curve values for boscalid and fluopyram were significantly lower for all five D123E-mutant isolates, demonstrating reduced disease control in vivo. In field trials, the frequency of A. solani isolates with the D123E mutation recovered from treatments receiving an in-furrow application of fluopyram ranged from 5 to 37%, which was significantly higher compared with treatments receiving foliar applications of standard protectants, in which the frequency of the D123E mutation in isolates ranged from 0 to 2.5%. Results suggest that A. solani isolates possessing the D123E mutation have a selective advantage under the application of fluopyram compared with SDHI-sensitive isolates, as well as isolates possessing other mutations conferring SDHI resistance. These data illustrate the importance of implementing fungicide resistance management strategies and cautions the use of fluopyram for in-furrow applications that target other pathogens of potato.
琥珀酸脱氢酶抑制剂 (SDHI) 杀菌剂已广泛应用于商业马铃薯 (Solanum tuberosum L.) 田,用于防治早疫病,该病由茄链格孢菌 (Alternaria solani Sorauer) 引起。在茄链格孢菌的三个 AsSdh 基因中,已经鉴定出五点突变可赋予对 SDHI 杀菌剂的抗性。我们实验室最近的工作表明,在一项为期 3 年的调查中,携带 D123E 突变的茄链格孢菌分离株,或在 AsSdhD 基因第 123 位天冬氨酸取代谷氨酸的取代,以更高的频率被连续收集。总共,118 个先前被鉴定为具有 D123E 突变的茄链格孢菌分离株在体外评估了 boscalid 和 fluopyram 的敏感性。超过 80%的具有 D123E 突变的茄链格孢菌分离株被确定为体外对 boscalid 高度耐药。然而,具有 D123E 突变的分离株对 fluopyram 的有效浓度抑制真菌生长的 50%值,范围从 0.2 到 3μg/ml,是敏感的,仅略高于基线分离株对 fluopyram 的有效浓度,范围从 0.1 到 0.6μg/ml。具有 D123E 突变的五个茄链格孢菌分离株在体内进一步评估了与两个野生型分离株相比,从 boscalid 和 fluopyram 获得的疾病控制百分比,三个分离株具有 F129L 突变,两个分离株具有 H134R 突变,两个分离株具有 H133R 突变,以及一个具有 H278R 突变的分离株。对于所有五个 D123E 突变分离株,boscalid 和 fluopyram 的相对剂量反应曲线下面积值显著降低,表明体内疾病控制能力降低。在田间试验中,从接受氟吡菌胺沟施处理中回收的具有 D123E 突变的茄链格孢菌分离株的频率为 5%至 37%,与接受标准保护剂叶面处理的处理相比,这一频率明显更高,在这些处理中,分离株中 D123E 突变的频率为 0 至 2.5%。结果表明,与 SDHI 敏感分离株以及具有其他赋予 SDHI 抗性突变的分离株相比,具有 D123E 突变的茄链格孢菌分离株在氟吡菌胺的应用下具有选择优势。这些数据说明了实施杀菌剂抗性管理策略的重要性,并警告不要将氟吡菌胺用于针对马铃薯其他病原体的沟施应用。